|
|
my account
log out
|
IP10-DT immunotoxin |
| Create: 03/30/2017 |
| Expired Date: | 03/18/2020 |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | This immunotoxin was achieved by conjugating/fusing the IP10 to Diphtheriatoxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to Th1 cells. Once bind, the toxin enters cells by receptor-mediated endocytosis, then Before the N-terminal 193 amino acids corresponding to the catalytic domain of DT enzyme; -II binding and elongation factor into the eukaryotic cell; the cell can catalyze specific elongation factor EF2 amide His699 of diphtheria ADP2 ribosylation occurs; thereby preventing protein synthesis and causes cell death. It was designed for treatment of Autoimmune diseases. |
| City: | Shirley[US]
|
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 270 | |
| Feb 01 2023 | GVBE Buffer | 278 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 278 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 273 | |
| Aug 30 2019 | Anti-HSV-2 gH Antibody | 463 | |
| Aug 30 2019 | Anti-L. major LPG Antibody | 545 | |
| Aug 30 2019 | Anti-DENV-1 Antibody | 453 | |
| Aug 30 2019 | Anti-BPV-1 L1 Antibody | 467 | |
| Aug 30 2019 | Anti-H3N2 HA Antibody | 455 | |
| Aug 30 2019 | Anti-EIAV env Antibody | 476 |
| Copyright © toextrade Inc. All rights reserved. Contact us |